Editas Medicine (EDIT) Treasury Shares (2015)

Editas Medicine (EDIT) has reported Treasury Shares for 11 consecutive years, with $595730.0 the latest figure, recorded in Q4 2025.

• In Q4 2025, Treasury Shares fell 74.39% year-over-year to $595730.0; the TTM figure through Dec 2025 stood at $595730.0 (down 74.39% YoY), while the FY2025 annual figure was $595730.0, down 74.39% from the prior year.
• Treasury Shares declined to $595730.0 in Q4 2025 per EDIT's latest filing, from $652267.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $2.7 million in Q1 2024 and bottomed at $595730.0 in Q4 2025.
• Historically, Treasury Shares has averaged $1.5 million across 5 years, with a median of $1.5 million in 2022.
• Annual changes were most pronounced in 2022 — Treasury Shares surged 138.43% — and 2025, when it tumbled 74.39%.
• Editas Medicine's Treasury Shares stood at $628732.0 in 2021, then soared by 138.43% to $1.5 million in 2022, then jumped by 40.56% to $2.1 million in 2023, then climbed by 10.41% to $2.3 million in 2024, then sank by 74.39% to $595730.0 in 2025.
• Business Quant data shows EDIT's Treasury Shares at $595730.0 in Q4 2025, $652267.0 in Q3 2025, and $923539.0 in Q2 2025.